• Goldenwell Biotech replaced its independent auditor, dismissing Michael Gillespie & Associates on Sept. 27, 2026.
• The former auditor’s reports for fiscal 2025 and 2024 included a going-concern warning over substantial doubt about the company’s ability to continue.
• No disputes were reported with the outgoing auditor on accounting, disclosure, or audit scope during those periods.
• The board engaged Privatco CPA Limited as the new independent registered public accounting firm, effective Sept. 22, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Goldenwell Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-005892), on September 29, 2026, and is solely responsible for the information contained therein.